Evaluation of Risk Determinants and Molecular Characterisation for Non-Primate Hepacivirus Infection in Turkish Horses
Abstract
1. Introduction
2. Materials and Methods
2.1. Acquisition and Processing of Field Samples
2.2. RNA Isolation, Reverse Transcription and PCR Assay
2.3. Sample Sequencing
2.4. Multiple Sequence and In Silico Analyses
2.5. Statistical Analyses
3. Results
3.1. Occurrence of NPHV in Serum Samples
3.2. Sequencing and Molecular Analyses
3.2.1. 5′ UTR
3.2.2. Partial NS3 Sequence
3.2.3. Partial NS5B Sequence
4. Discussion
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Abbreviations
| 5′ UTR | 5′ Untranslated Region |
| BIC | Bayesian Information Criterion |
| HPV | Hepacivirus |
| MAVS | Mitochondrial antiviral-signalling protein |
| MFE | Minimum Free Energy |
| NPHV | Non-Primate Hepacivirus |
| RdRP | RNA-dependent RNA Polymerase |
| SL | Stem-Loop |
| TRIF | TIR domain-containing adaptor protein inducing interferon beta |
References
- Tabata, K.; Neufeldt, C.J.; Bartenschlager, R. Hepatitis C Virus Replication. Cold Spring Harb. Perspect. Med. 2020, 10, a037093. [Google Scholar] [CrossRef]
- Baechlein, C.; Fischer, N.; Grundhoff, A.; Alawi, M.; Indenbirken, D.; Postel, A.; Baron, A.L.; Offinger, J.; Becker, K.; Beineke, A.; et al. Identification of a Novel Hepacivirus in Domestic Cattle from Germany. J. Virol. 2015, 89, 7007–7015. [Google Scholar] [CrossRef]
- Drexler, J.F.; Corman, V.M.; Muller, M.A.; Lukashev, A.N.; Gmyl, A.; Coutard, B.; Adam, A.; Ritz, D.; Leijten, L.M.; van Riel, D.; et al. Evidence for novel hepaciviruses in rodents. PLoS Pathog. 2013, 9, e1003438. [Google Scholar] [CrossRef] [PubMed]
- Quan, P.L.; Firth, C.; Conte, J.M.; Williams, S.H.; Zambrana-Torrelio, C.M.; Anthony, S.J.; Ellison, J.A.; Gilbert, A.T.; Kuzmin, I.V.; Niezgoda, M.; et al. Bats are a major natural reservoir for hepaciviruses and pegiviruses. Proc. Natl. Acad. Sci. USA 2013, 110, 8194–8199. [Google Scholar] [CrossRef] [PubMed]
- El-Attar, L.M.R.; Mitchell, J.A.; Brooks Brownlie, H.; Priestnall, S.L.; Brownlie, J. Detection of non-primate hepaciviruses in UK dogs. Virology 2015, 484, 93–102. [Google Scholar] [CrossRef] [PubMed]
- Tanaka, T.; Kasai, H.; Yamashita, A.; Okuyama-Dobashi, K.; Yasumoto, J.; Maekawa, S.; Enomoto, N.; Okamoto, T.; Matsuura, Y.; Morimatsu, M.; et al. Hallmarks of hepatitis C virus in equine hepacivirus. J. Virol. 2014, 88, 13352–13366. [Google Scholar] [CrossRef]
- Burbelo, P.D.; Dubovi, E.J.; Simmonds, P.; Medina, J.L.; Henriquez, J.A.; Mishra, N.; Wagner, J.; Tokarz, R.; Cullen, J.M.; Iadarola, M.J.; et al. Serology-enabled discovery of genetically diverse hepaciviruses in a new host. J. Virol. 2012, 86, 6171–6178. [Google Scholar] [CrossRef]
- Pybus, O.G.; Theze, J. Hepacivirus cross-species transmission and the origins of the hepatitis C virus. Curr. Opin. Virol. 2016, 16, 1–7. [Google Scholar] [CrossRef]
- Pronost, S.; Fortier, C.; Marcillaud-Pitel, C.; Tapprest, J.; Foursin, M.; Saunier, B.; Pitel, P.H.; Paillot, R.; Hue, E.S. Further Evidence for in Utero Transmission of Equine Hepacivirus to Foals. Viruses 2019, 11, 1124. [Google Scholar] [CrossRef]
- Scheel, T.K.; Kapoor, A.; Nishiuchi, E.; Brock, K.V.; Yu, Y.; Andrus, L.; Gu, M.; Renshaw, R.W.; Dubovi, E.J.; McDonough, S.P.; et al. Characterization of nonprimate hepacivirus and construction of a functional molecular clone. Proc. Natl. Acad. Sci. USA 2015, 112, 2192–2197. [Google Scholar] [CrossRef]
- Tomlinson, J.E.; Wolfisberg, R.; Fahnoe, U.; Patel, R.S.; Trivedi, S.; Kumar, A.; Sharma, H.; Nielsen, L.; McDonough, S.P.; Bukh, J.; et al. Pathogenesis, MicroRNA-122 Gene-Regulation, and Protective Immune Responses After Acute Equine Hepacivirus Infection. Hepatology 2021, 74, 1148–1163. [Google Scholar] [CrossRef] [PubMed]
- Gemaque, B.S.; Junior Souza de Souza, A.; do Carmo Pereira Soares, M.; Malheiros, A.P.; Silva, A.L.; Alves, M.M.; Gomes-Gouvea, M.S.; Pinho, J.R.; Ferreira de Figueiredo, H.; Ribeiro, D.B.; et al. Hepacivirus infection in domestic horses, Brazil, 2011–2013. Emerg. Infect. Dis. 2014, 20, 2180–2182. [Google Scholar] [CrossRef] [PubMed]
- Pfaender, S.; Cavalleri, J.M.; Walter, S.; Doerrbecker, J.; Campana, B.; Brown, R.J.; Burbelo, P.D.; Postel, A.; Hahn, K.; Anggakusuma; et al. Clinical course of infection and viral tissue tropism of hepatitis C virus-like nonprimate hepaciviruses in horses. Hepatology 2015, 61, 447–459. [Google Scholar] [CrossRef]
- Ramsay, J.D.; Evanoff, R.; Wilkinson, T.E., Jr.; Divers, T.J.; Knowles, D.P.; Mealey, R.H. Experimental transmission of equine hepacivirus in horses as a model for hepatitis C virus. Hepatology 2015, 61, 1533–1546. [Google Scholar] [CrossRef]
- Gather, T.; Walter, S.; Pfaender, S.; Todt, D.; Feige, K.; Steinmann, E.; Cavalleri, J.M.V. Acute and chronic infections with nonprimate hepacivirus in young horses. Vet. Res. 2016, 47, 97. [Google Scholar] [CrossRef]
- Figueiredo, A.S.; de Moraes, M.V.D.; Soares, C.C.; Chalhoub, F.L.L.; de Filippis, A.M.B.; dos Santos, D.R.L.; de Almeida, F.Q.; Godoi, T.L.O.S.; de Souza, A.M.; Burdman, T.R.; et al. First description of Theiler’s disease-associated virus infection and epidemiological investigation of equine pegivirus and equine hepacivirus coinfection in Brazil. Transbound. Emerg. Dis. 2019, 66, 1737–1751. [Google Scholar] [CrossRef]
- Lyons, S.; Kapoor, A.; Sharp, C.; Schneider, B.S.; Wolfe, N.D.; Culshaw, G.; Corcoran, B.; McGorum, B.C.; Simmonds, P. Nonprimate hepaciviruses in domestic horses, United Kingdom. Emerg. Infect. Dis. 2012, 18, 1976–1982. [Google Scholar] [CrossRef]
- Sarnow, P.; Sagan, S.M. Unraveling the Mysterious Interactions Between Hepatitis C Virus RNA and Liver-Specific MicroRNA-122. Annu. Rev. Virol. 2016, 3, 309–332. [Google Scholar] [CrossRef]
- Pacchiarotti, G.; Nardini, R.; Scicluna, M.T. Equine Hepacivirus: A Systematic Review and a Meta-Analysis of Serological and Biomolecular Prevalence and a Phylogenetic Update. Animals 2022, 12, 2486. [Google Scholar] [CrossRef]
- de Albuquerque, P.P.L.F.; Santos, L.H.S.; Antunes, D.; Caffarena, E.R.; Figueiredo, A.S. Structural insights into NS5B protein of novel equine hepaciviruses and pegiviruses complexed with polymerase inhibitors. Virus Res. 2020, 278, 197867. [Google Scholar] [CrossRef] [PubMed]
- Pronost, S.; Hue, E.; Fortier, C.; Foursin, M.; Fortier, G.; Desbrosse, F.; Rey, F.A.; Pitel, P.H.; Richard, E.; Saunier, B. Prevalence of Equine Infections in France and Evidence for Two Viral Subtypes Circulating Worldwide. Transbound. Emerg. Dis. 2017, 64, 1884–1897. [Google Scholar] [CrossRef]
- Tanaka, T.; Otoguro, T.; Yamashita, A.; Kasai, H.; Fukuhara, T.; Matsuura, Y.; Moriishi, K. Roles of the 5′ Untranslated Region of Nonprimate Hepacivirus in Translation Initiation and Viral Replication. J. Virol. 2018, 92, 10–1128. [Google Scholar] [CrossRef]
- Lohmann, V.; Korner, F.; Koch, J.; Herian, U.; Theilmann, L.; Bartenschlager, R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science 1999, 285, 110–113. [Google Scholar] [CrossRef]
- Romano, K.P.; Laine, J.M.; Deveau, L.M.; Cao, H.; Massi, F.; Schiffer, C.A. Molecular mechanisms of viral and host cell substrate recognition by hepatitis C virus NS3/4A protease. J. Virol. 2011, 85, 6106–6116. [Google Scholar] [CrossRef]
- Anggakusuma; Brown, R.J.P.; Banda, D.H.; Todt, D.; Vieyres, G.; Steinmann, E.; Pietschmann, T. Hepacivirus NS3/4A Proteases Interfere with MAVS Signaling in both Their Cognate Animal Hosts and Humans: Implications for Zoonotic Transmission. J. Virol. 2016, 90, 10670–10681. [Google Scholar] [CrossRef]
- Hernandez, S.; Diaz, A.; Loyola, A.; Villanueva, R.A. Recombinant HCV NS3 and NS5B enzymes exhibit multiple posttranslational modifications for potential regulation. Virus Genes 2019, 55, 227–232. [Google Scholar] [CrossRef] [PubMed]
- Powdrill, M.H.; Bernatchez, J.A.; Gotte, M. Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B. Viruses 2010, 2, 2169–2195. [Google Scholar] [CrossRef]
- Soriano, V.; Peters, M.G.; Zeuzem, S. New therapies for hepatitis C virus infection. Clin. Infect. Dis. 2009, 48, 313–320. [Google Scholar] [CrossRef]
- Lu, G.; Ou, J.J.; Sun, Y.K.; Wu, L.Y.; Xu, H.B.; Zhang, G.H.; Lj, S.J. Natural recombination of equine hepacivirus subtype 1 within the NS5A and NS5B genes. Virology 2019, 533, 93–98. [Google Scholar] [CrossRef] [PubMed]
- Scheel, T.K.; Galli, A.; Li, Y.P.; Mikkelsen, L.S.; Gottwein, J.M.; Bukh, J. Productive homologous and non-homologous recombination of hepatitis C virus in cell culture. PLoS Pathog. 2013, 9, e1003228. [Google Scholar] [CrossRef] [PubMed]
- TURKSTAT. Number of Other Animals by Type and Races. Available online: https://data.tuik.gov.tr/Bulten/DownloadIstatistikselTablo?p=G9Si2ZUtFqjRVYXBgpwaobojI5KMru9X66SjnBChzt7Rhy317YyqtFaa80fBpUzO (accessed on 26 August 2025).
- Kearse, M.; Moir, R.; Wilson, A.; Stones-Havas, S.; Cheung, M.; Sturrock, S.; Buxton, S.; Cooper, A.; Markowitz, S.; Duran, C.; et al. Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 2012, 28, 1647–1649. [Google Scholar] [CrossRef]
- Gruber, A.R.; Lorenz, R.; Bernhart, S.H.; Neubock, R.; Hofacker, I.L. The Vienna RNA websuite. Nucleic Acids Res. 2008, 36, W70–W74. [Google Scholar] [CrossRef]
- Guindon, S.; Dufayard, J.F.; Lefort, V.; Anisimova, M.; Hordijk, W.; Gascuel, O. New algorithms and methods to estimate maximum-likelihood phylogenies: Assessing the performance of PhyML 3.0. Syst. Biol. 2010, 59, 307–321. [Google Scholar] [CrossRef]
- Schwarz, G. Estimating the Dimension of a Model. Ann. Stat. 1978, 6, 461–464. [Google Scholar] [CrossRef]
- Martin, D.P.; Varsani, A.; Roumagnac, P.; Botha, G.; Maslamoney, S.; Schwab, T.; Kelz, Z.; Kumar, V.; Murrell, B. RDP5: A computer program for analyzing recombination in, and removing signals of recombination from, nucleotide sequence datasets. Virus Evol. 2021, 7, veaa087. [Google Scholar] [CrossRef]
- Benkert, P.; Biasini, M.; Schwede, T. Toward the estimation of the absolute quality of individual protein structure models. Bioinformatics 2011, 27, 343–350. [Google Scholar] [CrossRef] [PubMed]
- Bezerra, C.D.; Limeira, C.H.; dos Anjos, D.M.; Nogueira, D.B.; Morais, D.D.; Falcao, B.M.R.; Alves, C.J.; Santos, C.D.A.B.; Silva, M.L.C.R.; de Azevedo, S.S. Global Prevalence of RNA-Positive Horses for Hepacivirus (EqHV): Systematic Review and Meta-Analysis. J. Equine Vet. Sci. 2022, 114, 104003. [Google Scholar] [CrossRef]
- Date, T.; Sugiyama, M.; Lkhagvasuren, D.; Wakita, T.; Oyunsuren, T.; Mizokami, M. Prevalence of equine hepacivirus infection in Mongolia. Virus Res. 2020, 282, 197940. [Google Scholar] [CrossRef]
- Abbadi, I.; Lkhider, M.; Kitab, B.; Jabboua, K.; Zaidane, I.; Haddaji, A.; Nacer, S.; Matsuu, A.; Pineau, P.; Tsukiyama-Kohara, K.; et al. Non-primate hepacivirus transmission and prevalence: Novel findings of virus circulation in horses and dogs in Morocco. Infect. Genet. Evol. 2021, 93, 104975. [Google Scholar] [CrossRef] [PubMed]
- Nardini, R.; Pacchiarotti, G.; Svicher, V.; Salpini, R.; Bellocchi, M.C.; Conti, R.; Sala, M.G.; La Rocca, D.; Carioti, L.; Cersini, A.; et al. First National Prevalence in Italian Horse Population and Phylogenesis Highlight a Fourth Sub-Type Candidate of Equine Hepacivirus. Viruses 2024, 16, 616. [Google Scholar] [CrossRef]
- Leng, J.; Goldstein, D.R. Impact of aging on viral infections. Microbes Infect. 2010, 12, 1120–1124. [Google Scholar] [CrossRef] [PubMed]
- Reichert, C.; Campe, A.; Walter, S.; Pfaender, S.; Welsch, K.; Ruddat, I.; Sieme, H.; Feige, K.; Steinmann, E.; Cavalleri, J.M.V. Frequent occurrence of nonprimate hepacivirus infections in Thoroughbred breeding horses—A cross-sectional study for the occurrence of infections and potential risk factors. Vet. Microbiol. 2017, 203, 315–322. [Google Scholar] [CrossRef] [PubMed]
- Matsuu, A.; Hobo, S.; Ando, K.; Sanekata, T.; Sato, F.; Endo, Y.; Amaya, T.; Osaki, T.; Horie, M.; Masatani, T.; et al. Genetic and serological surveillance for non-primate hepacivirus in horses in Japan. Vet. Microbiol. 2015, 179, 219–227. [Google Scholar] [CrossRef]
- Kim, H.S.; Moon, H.W.; Sung, H.W.; Kwon, H.M. First identification and phylogenetic analysis of equine hepacivirus in Korea. Infect. Genet. Evol. 2017, 49, 268–272. [Google Scholar] [CrossRef]
- de Moraes, M.; Salgado, C.R.S.; Godoi, T.; de Almeida, F.Q.; Chalhoub, F.L.L.; de Filippis, A.M.B.; de Souza, A.M.; de Oliveira, J.M.; Figueiredo, A.S. Equine parvovirus-hepatitis is detected in South America, Brazil. Transbound. Emerg. Dis. 2022, 69, 3022–3027. [Google Scholar] [CrossRef]
- Yoon, J.; Park, T.; Kim, A.; Song, H.; Park, B.J.; Ahn, H.S.; Go, H.J.; Kim, D.H.; Lee, J.B.; Park, S.Y.; et al. First report of equine parvovirus-hepatitis and equine hepacivirus coinfection in horses in Korea. Transbound. Emerg. Dis. 2022, 69, 2735–2746. [Google Scholar] [CrossRef]
- Wu, L.; Ou, J.; Cai, S.; Ji, J.; Ren, Z.; Shao, R.; Li, S. First identification and genomic characterization of equine hepacivirus sub-type 3 strain in China. Virus Genes 2020, 56, 777–780. [Google Scholar] [CrossRef]
- Figueiredo, A.S.; Lampe, E.; de Albuquerque, P.; Chalhoub, F.L.L.; de Filippis, A.M.B.; Villar, L.M.; Cruz, O.G.; Pinto, M.A.; de Oliveira, J.M. Epidemiological investigation and analysis of the NS5B gene and protein variability of non-primate hepacivirus in several horse cohorts in Rio de Janeiro state, Brazil. Infect. Genet. Evol. 2018, 59, 38–47. [Google Scholar] [CrossRef]
- Figueiredo, A.S.; Lampe, E.; do Espirito-Santo, M.P.; Mello, F.C.; de Almeida, F.Q.; de Lemos, E.R.; Godoi, T.L.; Dimache, L.A.; Dos Santos, D.R.; Villar, L.M. Identification of two phylogenetic lineages of equine hepacivirus and high prevalence in Brazil. Vet. J. 2015, 206, 414–416. [Google Scholar] [CrossRef] [PubMed]
- Levinsson, A.; Zolopa, C.; Vakili, F.; Udhesister, S.; Kronfli, N.; Maheu-Giroux, M.; Bruneau, J.; Valerio, H.; Bajis, S.; Read, P.; et al. Sex and gender differences in hepatitis C virus risk, prevention, and cascade of care in people who inject drugs: Systematic review and meta-analysis. EClinicalMedicine 2024, 72, 102596. [Google Scholar] [CrossRef] [PubMed]
- Ng, W.C.; Soto-Acosta, R.; Bradrick, S.S.; Garcia-Blanco, M.A.; Ooi, E.E. The 5′ and 3′ Untranslated Regions of the Flaviviral Genome. Viruses 2017, 9, 137. [Google Scholar] [CrossRef]
- Vina-Rodriguez, A.; Sachse, K.; Ziegler, U.; Chaintoutis, S.C.; Keller, M.; Groschup, M.H.; Eiden, M. A Novel Pan-Flavivirus Detection and Identification Assay Based on RT-qPCR and Microarray. Biomed. Res. Int. 2017, 2017, 4248756. [Google Scholar] [CrossRef]
- Vilcek, S.; Herring, A.J.; Herring, J.A.; Nettleton, P.F.; Lowings, J.P.; Paton, D.J. Pestiviruses isolated from pigs, cattle and sheep can be allocated into at least three genogroups using polymerase chain reaction and restriction endonuclease analysis. Arch. Virol. 1994, 136, 309–323. [Google Scholar] [CrossRef]
- Naseri, A.; Anvari, E.; Mirnurollahi, S.; Fateh, A. Molecular prevalence and genotypic distribution of human pegivirus-1 among Iranian hemodialysis patients. Virus Res. 2025, 356, 199582. [Google Scholar] [CrossRef]
- Lattimer, J.; Stewart, H.; Locker, N.; Tuplin, A.; Stonehouse, N.J.; Harris, M. Structure-function analysis of the equine hepacivirus 5′ untranslated region highlights the conservation of translational mechanisms across the hepaciviruses. J. Gen. Virol. 2019, 100, 1501–1514. [Google Scholar] [CrossRef]
- Sun, C.; Querol-Audi, J.; Mortimer, S.A.; Arias-Palomo, E.; Doudna, J.A.; Nogales, E.; Cate, J.H. Two RNA-binding motifs in eIF3 direct HCV IRES-dependent translation. Nucleic Acids Res. 2013, 41, 7512–7521. [Google Scholar] [CrossRef] [PubMed]
- Frick, D.N.; Banik, S.; Rypma, R.S. Role of divalent metal cations in ATP hydrolysis catalyzed by the hepatitis C virus NS3 helicase: Magnesium provides a bridge for ATP to fuel unwinding. J. Mol. Biol. 2007, 365, 1017–1032. [Google Scholar] [CrossRef] [PubMed][Green Version]
- Dumont, S.; Cheng, W.; Serebrov, V.; Beran, R.K.; Tinoco, I., Jr.; Pyle, A.M.; Bustamante, C. RNA translocation and unwinding mechanism of HCV NS3 helicase and its coordination by ATP. Nature 2006, 439, 105–108. [Google Scholar] [CrossRef]
- Myong, S.; Bruno, M.M.; Pyle, A.M.; Ha, T. Spring-loaded mechanism of DNA unwinding by hepatitis C virus NS3 helicase. Science 2007, 317, 513–516. [Google Scholar] [CrossRef]
- Ma, Y.; Yates, J.; Liang, Y.; Lemon, S.M.; Yi, M. NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J. Virol. 2008, 82, 7624–7639. [Google Scholar] [CrossRef] [PubMed]
- Ralfs, P.; Bressanelli, S.; Gunter, L.M.; Gabel, A.; Rothhaar, P.; Price, K.J.; Tubiana, T.; Munschauer, M.; Frick, D.N.; Lohmann, V. Hepatitis C virus NS3 helicase contributes to (−) strand RNA synthesis. Nat. Commun. 2025, 16, 8006. [Google Scholar] [CrossRef]
- Kim, J.L.; Morgenstern, K.A.; Griffith, J.P.; Dwyer, M.D.; Thomson, J.A.; Murcko, M.A.; Lin, C.; Caron, P.R. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: The crystal structure provides insights into the mode of unwinding. Structure 1998, 6, 89–100. [Google Scholar] [CrossRef]
- Frick, D.N. HCV Helicase: Structure, Function, and Inhibition. In Hepatitis C Viruses: Genomes and Molecular Biology; Tan, S.L., Ed.; Horizon Bioscience: Norfolk, UK, 2006. [Google Scholar]
- Tai, C.L.; Pan, W.C.; Liaw, S.H.; Yang, U.C.; Hwang, L.H.; Chen, D.S. Structure-based mutational analysis of the hepatitis C virus NS3 helicase. J. Virol. 2001, 75, 8289–8297. [Google Scholar] [CrossRef][Green Version]
- Kim, D.W.; Kim, J.; Gwack, Y.; Han, J.H.; Choe, J. Mutational analysis of the hepatitis C virus RNA helicase. J. Virol. 1997, 71, 9400–9409. [Google Scholar] [CrossRef]
- Frick, D.N.; Rypma, R.S.; Lam, A.M.; Frenz, C.M. Electrostatic analysis of the hepatitis C virus NS3 helicase reveals both active and allosteric site locations. Nucleic Acids Res. 2004, 32, 5519–5528. [Google Scholar] [CrossRef] [PubMed]
- Lin, C.; Kim, J.L. Structure-based mutagenesis study of hepatitis C virus NS3 helicase. J. Virol. 1999, 73, 8798–8807. [Google Scholar] [CrossRef] [PubMed]
- Khalid, R.; Anwar, M.F.; Raees, M.A.; Naeem, S.; Abidi, S.H.; Ali, S. An in silico approach to analyze HCV genotype-specific binding-site variation and its effect on drug-protein interaction. Sci. Rep. 2020, 10, 20885. [Google Scholar] [CrossRef]
- Salam, K.A.; Akimitsu, N. Hepatitis C virus NS3 inhibitors: Current and future perspectives. Biomed. Res. Int. 2013, 2013, 467869. [Google Scholar] [CrossRef]
- Poch, O.; Sauvaget, I.; Delarue, M.; Tordo, N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 1989, 8, 3867–3874. [Google Scholar] [CrossRef]
- Behrens, S.E.; Tomei, L.; De Francesco, R. Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. 1996, 15, 12–22. [Google Scholar] [CrossRef] [PubMed]
- O’Farrell, D.; Trowbridge, R.; Rowlands, D.; Jager, J. Substrate complexes of hepatitis C virus RNA polymerase (HC-J4): Structural evidence for nucleotide import and de-novo initiation. J. Mol. Biol. 2003, 326, 1025–1035. [Google Scholar] [CrossRef]
- Ago, H.; Adachi, T.; Yoshida, A.; Yamamoto, M.; Habuka, N.; Yatsunami, K.; Miyano, M. Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure 1999, 7, 1417–1426. [Google Scholar] [CrossRef]
- Lesburg, C.A.; Cable, M.B.; Ferrari, E.; Hong, Z.; Mannarino, A.F.; Weber, P.C. Crystal structure of the RNA-dependent RNA polymerase from hepatitis C virus reveals a fully encircled active site. Nat. Struct. Biol. 1999, 6, 937–943. [Google Scholar] [CrossRef]
- Garriga, D.; Ferrer-Orta, C.; Querol-Audi, J.; Oliva, B.; Verdaguer, N. Role of motif B loop in allosteric regulation of RNA-dependent RNA polymerization activity. J. Mol. Biol. 2013, 425, 2279–2287. [Google Scholar] [CrossRef]
- te Velthuis, A.J. Common and unique features of viral RNA-dependent polymerases. Cell. Mol. Life Sci. 2014, 71, 4403–4420. [Google Scholar] [CrossRef] [PubMed]
- Jablonski, S.A.; Morrow, C.D. Mutation of the aspartic acid residues of the GDD sequence motif of poliovirus RNA-dependent RNA polymerase results in enzymes with altered metal ion requirements for activity. J. Virol. 1995, 69, 1532–1539. [Google Scholar] [CrossRef] [PubMed]
- Lohmann, V.; Overton, H.; Bartenschlager, R. Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP. J. Biol. Chem. 1999, 274, 10807–10815. [Google Scholar] [CrossRef]
- Vazquez, A.L.; Alonso, J.M.; Parra, F. Mutation analysis of the GDD sequence motif of a calicivirus RNA-dependent RNA polymerase. J. Virol. 2000, 74, 3888–3891. [Google Scholar] [CrossRef] [PubMed]
- Bello, A.S.; Uzairu, A.; Aadmu, S.G.; Ibrahim, A.; Mahmood, A.A.R.; Ibrahim, M.T. Molecular Dynamics Simulation, Molecular Docking, ADMET prediction, QSAR modeling and density functional theory computation for the identification of possible Hepatitis C Virus NS5B Protease inhibitors through in silico study of fluorine-2, 7-diamine compounds. Silico Res. Biomed. 2025, 1, 100104. [Google Scholar] [CrossRef]
- Noviandy, T.R.; Maulana, A.; Irvanizam, I.; Idroes, G.M.; Maulydia, N.B.; Tallei, T.E.; Subianto, M.; Idroes, R. Interpretable machine learning approach to predict Hepatitis C virus NS5B inhibitor activity using voting-based LightGBM and SHAP. Intell. Syst. Appl. 2025, 25, 200481. [Google Scholar] [CrossRef]




Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Atasoy, M.O.; Turan, T.; Özbek, R.; Işıdan, H.; Naggar, R.F.E.; Afify, A.F.; Rohaim, M.A. Evaluation of Risk Determinants and Molecular Characterisation for Non-Primate Hepacivirus Infection in Turkish Horses. Pathogens 2025, 14, 1256. https://doi.org/10.3390/pathogens14121256
Atasoy MO, Turan T, Özbek R, Işıdan H, Naggar RFE, Afify AF, Rohaim MA. Evaluation of Risk Determinants and Molecular Characterisation for Non-Primate Hepacivirus Infection in Turkish Horses. Pathogens. 2025; 14(12):1256. https://doi.org/10.3390/pathogens14121256
Chicago/Turabian StyleAtasoy, Mustafa Ozan, Turhan Turan, Remziye Özbek, Hakan Işıdan, Rania F. El Naggar, Ahmed F. Afify, and Mohammed A. Rohaim. 2025. "Evaluation of Risk Determinants and Molecular Characterisation for Non-Primate Hepacivirus Infection in Turkish Horses" Pathogens 14, no. 12: 1256. https://doi.org/10.3390/pathogens14121256
APA StyleAtasoy, M. O., Turan, T., Özbek, R., Işıdan, H., Naggar, R. F. E., Afify, A. F., & Rohaim, M. A. (2025). Evaluation of Risk Determinants and Molecular Characterisation for Non-Primate Hepacivirus Infection in Turkish Horses. Pathogens, 14(12), 1256. https://doi.org/10.3390/pathogens14121256

